Survivin
Cross-source consensus on Survivin from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Benefits
Preparation
Highlighted claims
- Survivin overexpression was tested in IGR37 ABCG2-negative cells at the day-98 beta-gal peak. — Senescent Cells in Growing Tumors: Population Dynamics and Cancer Stem Cells
- Survivin-GFP transfection reduced beta-gal activity compared with untransfected and GFP-only controls. — Senescent Cells in Growing Tumors: Population Dynamics and Cancer Stem Cells
- Survivin-GFP transfection increased colony growth measures in crystal violet assays. — Senescent Cells in Growing Tumors: Population Dynamics and Cancer Stem Cells
- Survivin is presented as a regulator that can reverse senescence-associated phenotypes under some molecular conditions. — Senescent Cells in Growing Tumors: Population Dynamics and Cancer Stem Cells
- Survivin primarily affected cells in the senescent state present at the beta-gal peak. — Senescent Cells in Growing Tumors: Population Dynamics and Cancer Stem Cells